These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7221994)

  • 1. [Comparative study of labetolol and propranolol in patients with untreated hypertension].
    Wessel-Aas T; Walstad RA; Berg KJ
    Tidsskr Nor Laegeforen; 1981 Mar; 101(9-10):579-81. PubMed ID: 7221994
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A; Allonen H; Kleimola T
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol and alprenolol. A comparative investigation of antihypertensive effect.
    Kofod P; Kjaer K; Vejlø S; Hvidt S
    Postgrad Med J; 1980; 56 Suppl 2():69-74. PubMed ID: 7001423
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of labetalol and propranolol in hypertension.
    Nicholls DP; Husaini MH; Bulpitt CJ; Stephens MD; Butler AG
    Br J Clin Pharmacol; 1980 Mar; 9(3):233-7. PubMed ID: 6988003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind study with oral labetalol (Trandate)--a new hypotensive agent.
    Nontak MA; Ahmad S; Maheendran KK; Abdullah Z
    Singapore Med J; 1980 Feb; 21(1):474-8. PubMed ID: 6994236
    [No Abstract]   [Full Text] [Related]  

  • 9. [Labetolol in the therapy of secondary arterial hypertension. A polycentric study].
    Palla R; Giusti R; Marchitiello M; Menicucci R
    Minerva Nefrol; 1982; 29(2):105-10. PubMed ID: 7133539
    [No Abstract]   [Full Text] [Related]  

  • 10. Labetalol in mild and moderate hypertension. A report from the General Practitioner Research Group.
    Practitioner; 1980 Sep; 224(1347):945-9. PubMed ID: 7003576
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Pedersen EB; Larsen JS
    Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
    Fea F; Salvioli G; Planca E; Pelliccioli I; Foti F; Colombo G
    Boll Soc Ital Cardiol; 1981; 26(12):2173-82. PubMed ID: 7185386
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol versus labetalol: interesting differences in efficacy.
    Flamenbaum W
    J Natl Med Assoc; 1985 May; 77 Suppl(Suppl):14-23. PubMed ID: 3889356
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of different antihypertensive therapies on plasma lipids.
    Gomez G
    Practitioner; 1982 May; 226(1367):985-91. PubMed ID: 7100090
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined alpha- and beta-adrenoreceptor blockade in hypertension: a controlled trial of labetalol (AH 5158) compared with propranolol and placebo.
    Pugsley D; Armstrong B; Nassim M; Beilin LJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():501s-503s. PubMed ID: 1071672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Apr; 73(14):845-9. PubMed ID: 7070696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Boll Soc Ital Cardiol; 1981; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract]   [Full Text] [Related]  

  • 18. A five-year study of labetalol in hypertension.
    Kane J; Gregg I; Stephens MD
    Practitioner; 1981 Jan; 225(1351):97-8, 100. PubMed ID: 7220466
    [No Abstract]   [Full Text] [Related]  

  • 19. Labetalol in the treatment of hypertension in patients with normal and impaired renal function.
    Walstad RA; Berg KJ; Wessel-Aas T; Nilsen OG
    Acta Med Scand Suppl; 1982; 665():135-41. PubMed ID: 6961760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.